UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Ischemic stroke market Insights: Rising prevalence of ischemic strokes boosts demand for effective treatment and prevention strategies.

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

MUMBAI: Kedaara Capital  is laying it on  thick with advisors. The latest to be added on its roster is Jai Shankar Krishnan as an operating advisor, effective immediately.  With over three decades of ...

Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...